Immune-mediated mechanisms of the inflammatory response in women with combined infections of the lower genital tract

Aim: to increase the effectiveness of combination therapy and reduce frequency of recurrences of inflammatory diseases in the lower genital tract of combined etiology.Materials and Мethods. There was conducted a prospective, randomized, blind, comparative clinical study. 80 women with vaginal microb...

Full description

Bibliographic Details
Main Authors: G. B. Dikke, A. A. Sukhanov, I. I. Kukarskaya, V. V. Ostromenskii
Format: Article
Language:Russian
Published: IRBIS LLC 2021-07-01
Series:Акушерство, гинекология и репродукция
Subjects:
Online Access:https://www.gynecology.su/jour/article/view/1005
_version_ 1797884067690053632
author G. B. Dikke
A. A. Sukhanov
I. I. Kukarskaya
V. V. Ostromenskii
author_facet G. B. Dikke
A. A. Sukhanov
I. I. Kukarskaya
V. V. Ostromenskii
author_sort G. B. Dikke
collection DOAJ
description Aim: to increase the effectiveness of combination therapy and reduce frequency of recurrences of inflammatory diseases in the lower genital tract of combined etiology.Materials and Мethods. There was conducted a prospective, randomized, blind, comparative clinical study. 80 women with vaginal microbiota disorders were examined randomized into 2 groups: group I (n = 40) – antibiotic therapy was carried out in combination with the preparation Superlimph, group II (n = 40) – a standalone antibacterial therapy; group III consisted of 20 patients lacking gynecological diseases considered to provide with control laboratory parameters. Clinical and laboratory methods were used: microscopy of vaginal smears, detection of viruses and sexually transmitted infections, measurement of serum cytokine levels – interleukins (IL-1â, IL-2, IL-4, IL-6, IL-8, IL-10), tumor necrosis factor alpha, (TNF-á), interferon gamma (IFN-ã).Results. It was found that clinical recovery occurred in 90.0 and 70.0 % of patients in group I and group II (р = 0.02), respectively. Microbiological recovery was observed in 100.0 and 67.5 % of patients, respectively (р = 0.003). In group I, the isolation of herpes simplex virus type 2 was found in 80.0 and 45.2 % of patients before and after treatment (p < 0.001), respectively, whereas in group II – in 82.5 and 77.5 %, respectively (p = 0.58), between groups – p < 0.001. Before treatment the level of all cytokines, excepting IFN-ã, was higher than the reference values in both groups: in group I, their magnitude decreased after treatment (p < 0.001) and corresponded to the reference values; in group II no changes occurred. Three months after treatment, no relapses were observed in group I, whereas frequency of relapses in group II was 22.5 %, within 1 year – 0 and 35.1 %, respectively. Predictors of recurrent dysbiosis (IL-2, IL-6 and TNF-á in increased concentrations after a course of treatment) were identified.Conclusion. Treatment with a combined broad-spectrum antimicrobial drug along with topical immunomodulatory agent containing exogenous cytokines is an effective strategy for treating concomitant dysbiosis and preventing relapse.
first_indexed 2024-04-10T04:01:43Z
format Article
id doaj.art-77f1bc2247704ee8a8d52f00ff0b92df
institution Directory Open Access Journal
issn 2313-7347
2500-3194
language Russian
last_indexed 2024-04-10T04:01:43Z
publishDate 2021-07-01
publisher IRBIS LLC
record_format Article
series Акушерство, гинекология и репродукция
spelling doaj.art-77f1bc2247704ee8a8d52f00ff0b92df2023-03-13T07:09:51ZrusIRBIS LLCАкушерство, гинекология и репродукция2313-73472500-31942021-07-0115324525710.17749/2313-7347/ob.gyn.rep.2021.209650Immune-mediated mechanisms of the inflammatory response in women with combined infections of the lower genital tractG. B. Dikke0A. A. Sukhanov1I. I. Kukarskaya2V. V. Ostromenskii3Academy of Medical Education named after F. I. InozemtsevTyumen State Medical University, Health Ministry of Russian FederationTyumen State Medical University, Health Ministry of Russian Federation; Tyumen Region Perinatal CenterAcademy of Medical Education named after F. I. InozemtsevAim: to increase the effectiveness of combination therapy and reduce frequency of recurrences of inflammatory diseases in the lower genital tract of combined etiology.Materials and Мethods. There was conducted a prospective, randomized, blind, comparative clinical study. 80 women with vaginal microbiota disorders were examined randomized into 2 groups: group I (n = 40) – antibiotic therapy was carried out in combination with the preparation Superlimph, group II (n = 40) – a standalone antibacterial therapy; group III consisted of 20 patients lacking gynecological diseases considered to provide with control laboratory parameters. Clinical and laboratory methods were used: microscopy of vaginal smears, detection of viruses and sexually transmitted infections, measurement of serum cytokine levels – interleukins (IL-1â, IL-2, IL-4, IL-6, IL-8, IL-10), tumor necrosis factor alpha, (TNF-á), interferon gamma (IFN-ã).Results. It was found that clinical recovery occurred in 90.0 and 70.0 % of patients in group I and group II (р = 0.02), respectively. Microbiological recovery was observed in 100.0 and 67.5 % of patients, respectively (р = 0.003). In group I, the isolation of herpes simplex virus type 2 was found in 80.0 and 45.2 % of patients before and after treatment (p < 0.001), respectively, whereas in group II – in 82.5 and 77.5 %, respectively (p = 0.58), between groups – p < 0.001. Before treatment the level of all cytokines, excepting IFN-ã, was higher than the reference values in both groups: in group I, their magnitude decreased after treatment (p < 0.001) and corresponded to the reference values; in group II no changes occurred. Three months after treatment, no relapses were observed in group I, whereas frequency of relapses in group II was 22.5 %, within 1 year – 0 and 35.1 %, respectively. Predictors of recurrent dysbiosis (IL-2, IL-6 and TNF-á in increased concentrations after a course of treatment) were identified.Conclusion. Treatment with a combined broad-spectrum antimicrobial drug along with topical immunomodulatory agent containing exogenous cytokines is an effective strategy for treating concomitant dysbiosis and preventing relapse.https://www.gynecology.su/jour/article/view/1005vaginal microbiotadysbiosisimmunitycytokinessuperlymph
spellingShingle G. B. Dikke
A. A. Sukhanov
I. I. Kukarskaya
V. V. Ostromenskii
Immune-mediated mechanisms of the inflammatory response in women with combined infections of the lower genital tract
Акушерство, гинекология и репродукция
vaginal microbiota
dysbiosis
immunity
cytokines
superlymph
title Immune-mediated mechanisms of the inflammatory response in women with combined infections of the lower genital tract
title_full Immune-mediated mechanisms of the inflammatory response in women with combined infections of the lower genital tract
title_fullStr Immune-mediated mechanisms of the inflammatory response in women with combined infections of the lower genital tract
title_full_unstemmed Immune-mediated mechanisms of the inflammatory response in women with combined infections of the lower genital tract
title_short Immune-mediated mechanisms of the inflammatory response in women with combined infections of the lower genital tract
title_sort immune mediated mechanisms of the inflammatory response in women with combined infections of the lower genital tract
topic vaginal microbiota
dysbiosis
immunity
cytokines
superlymph
url https://www.gynecology.su/jour/article/view/1005
work_keys_str_mv AT gbdikke immunemediatedmechanismsoftheinflammatoryresponseinwomenwithcombinedinfectionsofthelowergenitaltract
AT aasukhanov immunemediatedmechanismsoftheinflammatoryresponseinwomenwithcombinedinfectionsofthelowergenitaltract
AT iikukarskaya immunemediatedmechanismsoftheinflammatoryresponseinwomenwithcombinedinfectionsofthelowergenitaltract
AT vvostromenskii immunemediatedmechanismsoftheinflammatoryresponseinwomenwithcombinedinfectionsofthelowergenitaltract